Acute motor axonal neuropathy in association with Sjögren syndrome

Muscle and Nerve

Volumn 42, Issue 5, 2010, Pages 828-830

  Awad, Amer ^a   Mathew, Sani ^b   Katirji, Bashar ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

AMAN; Anti GM1 antibody; Guillain Barr IVIg; Sj gren's syndrome; SS A antibody; Syndrome

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY;

ACUTE MOTOR AXONAL NEUROPATHY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOLOGICAL PROCEDURES; MALE; MOTOR NEUROPATHY; MUSCLE ACTION POTENTIAL; PRIORITY JOURNAL; SJOEGREN SYNDROME; XEROPHTHALMIA; XEROSTOMIA;

ACTION POTENTIALS; ADULT; AXONS; ELECTRODIAGNOSIS; G(M1) GANGLIOSIDE; HUMANS; MALE; MOTOR NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; QUADRIPLEGIA; SJOGREN'S SYNDROME;

EID: 78149336657     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21830     Document Type: Article

References (17)

1. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-291.
2. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-354.
3. Segal B, Carpenter A, Walk D. Involvement of nervous system pathways in primary Sjögren's syndrome. Rheum Dis Clin N Am 2008;34:885-906.
4. Lafitte C, Amoura Z, Cacoub P, Pradat-Diehl P. Neurologic complications of primary Sjögren's syndrome. J Neurol 2001;248:577-584.
5. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: an update. J Clin Neurosci 2009;16:733-741.
6. Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366:1653-1663.
7. Alpa M, Ferrero B, Cavallo R, Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitis. Clin Exp Rheumatol 2007;25:556-562.
8. Mochizuki H, Kamakura K, Masaki T, Hirata A, Nakamura R, Motoyoshi K. Motor dominant neuropathy in Sjögren's syndrome: report of two cases. Intern Med 2002;41:142-146.
9. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996;55:116-121.
10. Fox RI, Chan EK, Kang HI. Laboratory evaluation of patients with Sjögren's syndrome. Clin Biochem 1992;25:213-222.
11. Nikolov NP, Illei GG. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009;21:465-470.
12. Fox RI. Sjögren's syndrome. Lancet 2005;366:321-331.
13. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128:2518-2534.
14. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005;38:55-63.
15. Ubogu EE, Zaidat OO, Suarez JI. Acute motor-sensory neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies. J Clin Rheumatol 2001;7:326-331.
16. Kuwabara S, Mori M, Ogawara K, Hattori T, Oda S, Koga M, et al. Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody. Muscle Nerve 2001;24:54-58.
17. Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007;130:2245-2257.